E-LIB Suche - Ergebnisse für: Brieva-Ruiz, L

1

Gadolinium-enhanced brain lesions in multiple sclerosis rel..:

Martín-Aguilar, L. ; Presas-Rodriguez, S. ; Rovira, À....
Neurología (English Edition). 37 (2022) 7 - p. 557-563 , 2022

Link: https://doi.org/10.1016/..

2

Gadolinium-enhanced brain lesions in multiple sclerosis rel..:

Martín-Aguilar, L. ; Presas-Rodriguez, S. ; Rovira, À....
Neurología. 37 (2022) 7 - p. 557-563 , 2022

Link: https://doi.org/10.1016/..

3

Anti-Ri-associated paraneoplastic cerebellar degeneration a..:

Brieva-Ruíz, L. ; Diaz-Hurtado, M. ; Matias-Guiu, X....
Clinical Neurology and Neurosurgery. 110 (2008) 10 - p. 1044-1046 , 2008

Link: https://doi.org/10.1016/..

4

Preventive treatment can reverse cognitive impairment in ch..:

González-Mingot, Cristina ; Gil-Sánchez, Anna ; Canudes-Solans, Marc...
The Journal of Headache and Pain. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

5

The efficacy of combining topiramate and 4-aminopyridine to..:

González-Mingot, Cristina ; López-Ortega, Ricard ; Brieva-Ruiz, Luis
Neurological Sciences. 43 (2022) 8 - p. 5099-5101 , 2022

Link: https://doi.org/10.1007/..

6

Gadolinium-enhanced brain lesions in multiple sclerosis rel..:

L. Martín-Aguilar ; S. Presas-Rodriguez ; À. Rovira...
http://www.sciencedirect.com/science/article/pii/S2173580822000700. , 2022

Link: https://doi.org/10.1016/..

7

Efficacy and safety of masitinib in progressive forms of mu..:

Vermersch, P ; Brieva-Ruiz, L ; Fox, R.J...
http://edoc.mdc-berlin.de/21370/1/21370oa.pdf. , 2022

Link: http://edoc.mdc-berlin.d..

8

Documento de consenso de la Sociedad Española de Neurología..:

Meca-Lallana, J.E. ; Martínez Yélamos, S. ; Eichau, S....
Neurología. 39 (2024) 2 - p. 196-208 , 2024

Link: https://doi.org/10.1016/..

9

Consensus statement of the Spanish Society of Neurology on ..:

Meca-Lallana, J.E. ; Martínez Yélamos, S. ; Eichau, S....
Neurología (English Edition). 39 (2024) 2 - p. 196-208 , 2024

Link: https://doi.org/10.1016/..

10

Consensus statement on the use of alemtuzumab in daily clin..:

Meca-Lallana, J.E. ; Fernández-Prada, M. ; García Vázquez, E....
Neurología (English Edition). 37 (2022) 8 - p. 615-630 , 2022

Link: https://doi.org/10.1016/..

11

Consenso de expertos sobre el uso de alemtuzumab en la prác..:

Meca-Lallana, J.E. ; Fernández-Prada, M. ; García Vázquez, E....
Neurología. 37 (2022) 8 - p. 615-630 , 2022

Link: https://doi.org/10.1016/..

12

Preventive treatment can reverse cognitive impairment in ch..:

González-Mingot, Cristina ; Gil-Sánchez, Anna ; Canudes-Solans, Marc...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476561/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Efficacy and Safety of Masitinib in Progressive Forms of Mu..:

Vermersch, Patrick ; Brieva-Ruiz, Luis ; Fox, Robert J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005047/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Cardiogenic shock in clinically isolated syndrome:

González Mingot, C. ; Juárez Turégano, A. ; Bosch Gaya, A..
Neurología (English Edition). 34 (2019) 1 - p. 69-72 , 2019

Link: https://doi.org/10.1016/..

15

Shock cardiogénico en síndrome clínico aislado:

González Mingot, C. ; Juárez Turégano, A. ; Bosch Gaya, A..
Neurología. 34 (2019) 1 - p. 69-72 , 2019

Link: https://doi.org/10.1016/..